Evidence map›Paper›PMID 38405760›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology.

Hoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, Elias K Haddad, Patrice M Becker, Seunghee Kim-Schulze, Brian Lee, Jing Chen, Annmarie Hoch, Harry Pickering and 23 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors at 12 institutions in 1 country.

Hoang Van PhanUniversity of California San Francisco.
Alexandra TsitsiklisUniversity of California San Francisco.
Cole P MaguireUniversity of Texas Austin.ORCID 0000-0001-8986-9762
Elias K HaddadDrexel University/Tower Health Hospital.
Patrice M BeckerNational Institute of Allergy and Infectious Diseases/National Institutes of Health.
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai.
Brian LeeIcahn School of Medicine at Mount Sinai.
Jing ChenPrecision Vaccines Program, Boston Children's Hospital.
Annmarie HochPrecision Vaccines Program, Boston Children's Hospital.
Harry PickeringDavid Geffen School of Medicine, University of California Los Angeles.
Patrick Van ZalmPrecision Vaccines Program, Boston Children's Hospital.
Matthew C AltmanBenaroya Research Institute.
Alison D AugustineNational Institute of Allergy and Infectious Diseases/National Institutes of Health.
Carolyn S CalfeeUniversity of California San Francisco.
Steve BosingerEmory University.
Charles CairnsDrexel University/Tower Health Hospital.
Walter EckalbarUniversity of California San Francisco.
Leying GuanYale School of Public Health.
Naresh Doni JayaveluBenaroya Research Institute.
Steven H KleinsteinYale School of Medicine.
Florian KrammerIcahn School of Medicine at Mount Sinai.
Holden T MaeckerStanford University.
Al OzonoffPrecision Vaccines Program, Boston Children's Hospital.ORCID 0000-0003-4233-5899
Bjoern PetersLa Jolla Institute for Immunology.
Nadine RouphaelEmory University.
IMPACC Network
Ruth R MontgomeryYale School of Medicine.
Elaine ReedDavid Geffen School of Medicine, University of California Los Angeles.
Joanna SchaenmanDavid Geffen School of Medicine, University of California Los Angeles.
Hanno SteenPrecision Vaccines Program, Boston Children's Hospital.ORCID 0000-0003-0179-6648
Ofer LevyPrecision Vaccines Program, Boston Children's Hospital.ORCID 0000-0002-5859-1945
Joann Diray-ArcePrecision Vaccines Program, Boston Children's Hospital.ORCID 0000-0003-2183-4269
Charles R LangelierUniversity of California San Francisco.
Boston Children's Hospital · USUniversity of California, San Francisco · USIcahn School of Medicine at Mount Sinai · USUniversity of California, Los Angeles · USYale University · USBenaroya Research InstituteDrexel University · USEmory University · USNational Institutes of Health · USLa Jolla Institute for Immunology · USStanford University · USThe University of Texas at Austin · US

Funding

Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2004 to 2023
$56.2M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
Project 3 - Ex vivo immune profiling of dengue viruses and vaccinesU19AI118610 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KASARSKIS, ANDREW · 2015 to 2021
$46.6M
Systems Biological Analysis of Innate and Adaptive Responses to VaccinationU19AI090023 · NIAID · EMORY UNIVERSITY · PI AHMED, RAFI, LI, SHUZHAO · 2010 to 2021
$45.0M
Understanding Asthma EndotypesU19AI077439 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle · 2008 to 2026
$41.1M
Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OZONOFF, AL · 2017 to 2021
$24.7M
Tollip inhibits IL-33 signaling during airway influenza virus infectionU19AI125357 · NIAID · UNIVERSITY OF ARIZONA · PI KRAFT, MONICA · 2016 to 2025
$14.7M
Systems Immunology profiling of respiratory viral infections in vulnerable populationsU19AI167891 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Matthew C. Altman, Carmen R Mikacenic · 2022 to 2026
$14.0M
Project 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV InfectionU19AI128913 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REED, ELAINE F, SARWAL, MINNIE M · 2017 to 2021
$11.2M
The contribution of GPCRs to thymocyte medullary entry and central toleranceR01AI104870 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI Lauren Ilyse Richie EHRLICH · 2014 to 2026
$7.6M
Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination. U19AI128910 · NIAID · DREXEL UNIVERSITY · PI KALEEBU, PONTIANO · 2017 to 2021
$7.0M
NIAID NIH HHS R01 AI104870NIAID NIH HHS R01 AI122220NIAID NIH HHS R01 AI132774NIAID NIH HHS R01 AI135803NIAID NIH HHS R01 AI145835NIAID NIH HHS U19 AI057229NIAID NIH HHS U19 AI062629NIAID NIH HHS U19 AI077439NIAID NIH HHS U19 AI089992NIAID NIH HHS U19 AI090023NIAID NIH HHS U19 AI118608NIAID NIH HHS U19 AI118610NIAID NIH HHS U19 AI125357NIAID NIH HHS U19 AI128910NIAID NIH HHS U19 AI128913NIAID NIH HHS U54 AI142766
6 · The paper itself

Abstract

Age is a major risk factor for severe coronavirus disease-2019 (COVID-19), yet the mechanisms responsible for this relationship have remained incompletely understood. To address this, we evaluated the impact of aging on host and viral dynamics in a prospective, multicenter cohort of 1,031 patients hospitalized for COVID-19, ranging from 18 to 96 years of age. We performed blood transcriptomics and nasal metatranscriptomics, and measured peripheral blood immune cell populations, inflammatory protein expression, anti-SARS-CoV-2 antibodies, and anti-interferon (IFN) autoantibodies. We found that older age correlated with an increased SARS-CoV-2 viral load at the time of admission, and with delayed viral clearance over 28 days. This contributed to an age-dependent increase in type I IFN gene expression in both the respiratory tract and blood. We also observed age-dependent transcriptional increases in peripheral blood IFN-γ, neutrophil degranulation, and Toll like receptor (TLR) signaling pathways, and decreases in T cell receptor (TCR) and B cell receptor signaling pathways. Over time, older adults exhibited a remarkably sustained induction of proinflammatory genes (e.g.,

Identifiers

PMID38405760
PMCPMC10888993
OpenAlexW4391799423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.